E
Encompass Health Corporation (EHC)
NYQ – Real Time Price. Currency in USD
97.57
-0.17 (-0.17%)
At close: Mar 27, 2026, 4:00 PM EDT
97.57
0.00 (0.00%)
After-hours: Mar 27, 2026, 6:16 PM EDT
Get all premium features to the best stock analysis tool
NYQ – Real Time Price. Currency in USD
97.57
-0.17 (-0.17%)
At close: Mar 27, 2026, 4:00 PM EDT
97.57
0.00 (0.00%)
After-hours: Mar 27, 2026, 6:16 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.08 | 1.59 | 7.0 | |
| Quick ratio | 1.08 | 1.27 | 7.0 | |
| Debt to Equity | 1.11 | 0.27 | 6.0 | |
| Debt to Assets | 0.38 | 0.72 | 6.0 | |
| Interest coverage | 9.38 | 25.51 | 10 | |
| Weighted average score | 7.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 4.35B | 4.80B | 5.37B | 5.94B | 5.94B |
| Gross Profit | 785M | 934M | 1.07B | 1.29B | 1.29B |
| Operating Income | 630M | 732M | 865M | 1.05B | 1.05B |
| Net Income | 270M | 350M | 453M | 565M | 565M |
| EBITDA | 874M | 1.01B | 1.16B | 1.38B | 1.38B |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 8.27 | 9.74 | 6.0 |
| Next quarter | 8.21 | 6.11 | 5.5 |
| Current year | 8.25 | 8.63 | 6.0 |
| Next year | 8.04 | 9.36 | 6.0 |
| Weighted average score | 5.9 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 4.54 | 15.45 | 18.7 | 39.43 | 8.0 |
| Y/Y | 9.94 | 21.32 | 24.79 | 45.69 | 9.0 |
| 3y average | 10.93 | 27.94 | 24.15 | 48.78 | 9.3 |
| 5y average | 5.51 | 18.9 | 17.24 | 16.41 | 8.0 |
| Weighted average score | 8.6 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.62 | 0.62 | 4.0 |
| Payout ratio | 13.11 | 13.11 | 3.0 |
| 5-year dividend growth rate | -13.90 | -13.90 | 1.0 |
| Years of dividend increase | 3.00 | 3.00 | 3.0 |
| Weighted average score | 2.8 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | Wide | 8.0 |
| Intangible assets | Medium | 7.0 |
| Switching costs | Medium | 7.0 |
| Network effect | Narrow | 4.0 |
| Economies of scale | Medium | 7.0 |
| Weighted average score | 6.6 | |
Total debt $2.7B significantly exceeds cash reserves ($102.9M), raising financial stability concerns
Total current assets $905.9M exceed Total current liabilities $836.4M, highlighting excellent liquidity
Debt-to-equity ratio (0.8) is near the industry average, reflecting balanced leverage
Interest coverage ratio (9x) indicates the company easily manages its debt payments
The company generates positive free cash flow $116.7M, supporting its financial health